Services · NSE: GPPL
Gujarat Pipavav Port
Q2 FY27 earnings highlights, from the results presentation
- M.Cap
- ₹8,520Cr
- P/E
- 15.5×
- 1Y return
- +1.04%
- From 52W high
- −11.9%
Highlights are read by AI from the company's filing and can contain mistakes. Check the source page linked to each line.
Share price
Results Q2 FY27, as filed · consolidated · ₹ Cr
| Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ | |
|---|---|---|---|---|---|
| Revenue | 339 | 299 | +13.3% | 332 | +2.2% |
| EBITDA | 212 | 178 | +19.1% | 214 | -1.0% |
| EBITDA margin | 62.5% | 59.4% | +305 bps | 64.5% | -204 bps |
| One-off items | — | 43 | — | — | — |
| PBTProfit before tax | 197 | 208 | -5.3% | 197 | -0.2% |
| Net profit | 153 | 161 | -5.0% | 148 | +3.2% |
| EPS (₹) | 3.16 | 3.32 | -4.8% | 3.06 | +3.3% |
From the company's own results filing on NSE. Net profit is the owners' share. Growth and the dotted lines are worked out from the filed figures. In Q2 FY27 the filing tags the owners' profit as ₹0 Cr against its own period profit; the period profit less minority interest is shown.
In short
- 01Q2 FY27 revenue rose 13% year on year, on higher container and RORO revenue.
- 02Q2 EBITDA margin was 62%, up 300 basis points.
- 03Q2 net profit fell 6% year on year; excluding last year's insurance recovery it rose 18%.
- 04Q2 container volume was 192,944 TEUs; the Middle East conflict affected container, bulk and liquid volumes.
- 05RORO volumes rose on higher exports from OEMs.
- 06Half-year revenue rose 16% and net profit 20%, excluding duty benefit scrips revenue and cyclone recovery.
Demand
Margins and costs
Q2 expenses higher by 5%
Slides · p. 5
Q2 expenses higher by 5%
“▪ Expenses higher by 5%”
Q2 EBITDA margin at 62%, up 300 basis points
Slides · p. 5
Q2 EBITDA margin at 62%, up 300 basis points
“▪ EBITDA Margin at 62% up by 300 basis point”
H1 EBITDA higher by 21% and EBIT higher by 27%, on adjusted basis
Slides · p. 6
H1 EBITDA higher by 21% and EBIT higher by 27%, on adjusted basis
“• EBITDA higher by 21% • EBIT higher by 27%”
Q2 EBITDA Rs 2,118.20 million, up 19% year on year
Slides · p. 8
Q2 EBITDA Rs 2,118.20 million, up 19% year on year
“EBITDA 2,118.20 2,139.83 -1% 1,776.34 19% 4,258.03 3,249.13 31%”
H1 expenses higher by 9%
Slides · p. 6
H1 expenses higher by 9%
“• Expenses higher by 9%”
Debt and working capital
Q2 finance cost Rs 10.42 million
Slides · p. 8
Q2 finance cost Rs 10.42 million
“Finance Cost 10.42 7.17 45% 14.65 -29% 17.59 33.35 -47%”
One-offs
Risks
Middle East conflict affected container transhipment and bulk fertilizer and mineral imports
Slides · p. 5
Middle East conflict affected container transhipment and bulk fertilizer and mineral imports
“▪ Middle East conflict: (+18%) (-10%) • Container: Transhipment volume • Bulk: Lower fertilizer & Mineral imports”
Other
Q2 revenue higher by 13%, on higher container and RORO revenue
Slides · p. 5
Q2 revenue higher by 13%, on higher container and RORO revenue
“▪ Revenue higher by 13%; Higher Container & RORO revenue”
Container: Q2 container volume 192,944 TEUs; dry bulk 942,575 MT
Slides · p. 5
Container: Q2 container volume 192,944 TEUs; dry bulk 942,575 MT
“CONTAINER (TEUs) DRY BULK (MT) 192,944 942,575”
Q2 net profit Rs 1,484.85 million, down 6% year on year
Slides · p. 8
Q2 net profit Rs 1,484.85 million, down 6% year on year
“Net Profit 1,484.85 1,468.77 1% 1,576.41 -6% 2,953.62 2,583.68 14%”
Q2 revenue from operations Rs 3,391.52 million
Slides · p. 8
Q2 revenue from operations Rs 3,391.52 million
“Revenue from Operations 3,391.52 3,317.67 2% 2,991.49 13% 6,709.19 5,492.78 22%”
H1 revenue higher by 16%, excluding duty benefit scrips revenue and cyclone recovery
Slides · p. 6
H1 revenue higher by 16%, excluding duty benefit scrips revenue and cyclone recovery
“▪ Excluding duty benefit scrips revenue & cyclone recovery: REVENUE EBITDA • Revenue higher by 16%; Container & RORO”
Sources
- Investor presentation, Q2 FY27 Filed 4 Nov 2026 · 9 pages
Management's own statements, quoted from its NSE filings. This page was read by AI and can contain mistakes: check the source pages before relying on any figure. No forecast or opinion of ours. Not investment advice.

